Bigbear Pharmaceutical·Medication Guide

• How Much Does Pralsetinib Cost?

  The price of Pralsetinib varies depending on the region, medical insurance policies, and drug specifications. In the domestic market, the price is typ···【Read More】

  Update: 2026-03-24Source: Haiou HealthViews: 155

• How much does a box of pralatinib cost?

  The price of pralatinib varies depending on the strength, region, and purchase channel, typically ranging from 30,000 to 50,000 yuan per box. The spec···【Read More】

  Update: 2026-03-24Source: Haiou HealthViews: 151

• I. Price through Domestic Medical Insurance Reimbursement

  The price of pralatinib varies significantly depending on the drug version, strength, whether it is covered by medical insurance, and the purchase cha···【Read More】

  Update: 2026-03-24Source: Haiou HealthViews: 169

• Terpotinib Dosage Guidelines

  Tepotinib use must strictly adhere to individualized treatment principles. The dosage and administration method should be determined by a specialist p···【Read More】

  Update: 2026-03-23Source: Haiou HealthViews: 175

• RET inhibitor pralsetinib seeks marketing approval in the US for thyroid cancer.

  CStone Pharmaceuticals partner Blueprint Medicines recently announced that it has submitted a New Drug Application (NDA) to the US Food and Drug Admin···【Read More】

  Update: 2026-03-23Source: Haiou HealthViews: 161

• Gavreto (pralsetinib), a novel RET kinase inhibitor for non-small cell lung cancer, has been approve

  Blueprint Medicines recently announced that the U.S. Food and Drug Administration (FDA) has approved Gavreto (pralsetinib), a precision oncology drug,···【Read More】

  Update: 2026-03-23Source: Haiou HealthViews: 149

• New Drug for RET Fusion-Positive Thyroid Cancer - Gavreto (pralsetinib Capsules) - Product Informati

  Recently, the U.S. Food and Drug Administration (FDA) approved Gavreto (pralsetinib) capsules, a precision oncology drug and RET kinase inhibitor, for···【Read More】

  Update: 2026-03-23Source: Haiou HealthViews: 157

• China's First Selective RET Inhibitor, pralsetinib, Approved for Marketing in the Treatment of

  China's National Medical Products Administration (NMPA) recently approved Prugihua® (pralsetinib capsules) as a Class 1 New Drug Application for t···【Read More】

  Update: 2026-03-23Source: Haiou HealthViews: 217

• FDA Fully Approves Gavreto (pralsetinib) for the Treatment of RET Gene Fusions in Non-Small Cell Lun

  The U.S. Food and Drug Administration (FDA) announced on August 9 that it has fully approved Gavreto (pralsetinib) for the treatment of adult patients···【Read More】

  Update: 2026-03-23Source: Haiou HealthViews: 201

• Tagrisso (Osimertinib) Approved in the UK for Two Lung Cancer Indications

  Last Friday, the UK's National Institute for Health and Care Evaluation (NICE) reversed its earlier rejection of AstraZeneca's lung cancer the···【Read More】

  Update: 2026-03-23Source: Haiou HealthViews: 189

• Tagrisso in combination with chemotherapy has been approved in the United States

  AstraZeneca recently announced that its supplemental New Drug Application (sNDA) for Tagrisso (osimertinib), an epidermal growth factor receptor (EGFR···【Read More】

  Update: 2026-03-23Source: Haiou HealthViews: 166

• TAGRISSO (Osimertinib) Drug Guidelines

  The U.S. Food and Drug Administration (FDA) has approved TAGRISSO (osimertinib) for first-line treatment of patients with metastatic non-small cell lu···【Read More】

  Update: 2026-03-23Source: Haiou HealthViews: 169

• Tagrisso Approved for New Indication: Treatment of Stage III Unresectable EGFR-Mutant NSCLC

  AstraZeneca announced yesterday that the U.S. Food and Drug Administration (FDA) has approved its epidermal growth factor receptor (EGFR) tyrosine kin···【Read More】

  Update: 2026-03-23Source: Haiou HealthViews: 169

• Which other drugs may interact with binimetinib?

  Certain medications may interact with binimetinib, including prescription drugs, over-the-counter medicines, vitamins, and herbal supplements. Inform ···【Read More】

  Update: 2026-03-23Source: Haiou HealthViews: 172

• What should I avoid while taking binimetinib?

  Follow your physician’s guidance regarding any restrictions on food, beverages, or physical activity.【Read More】

  Update: 2026-03-23Source: Haiou HealthViews: 181